Moderna, Pfizer Nab Unanimous Votes For Pediatric COVID Vaccines But Advisors Hint At Moderna Dosing Advantage

 
• By Sarah Karlin-Smith

US FDA advisory committee members raised some concerns regarding Pfizer’s three-dose schedule for children under five, suggesting Moderna’s two-dose primary series may be preferred.

blocks that say 2nd and third dose
FDA advisors signaled some preference for Moderna’s two-shot COVID-19 vaccine schedule in the youngest Americans over Pfizer’s three-shot series. • Source: Shutterstock

More from United States

More from North America